Drug
Candesartan cilexetil clinical trials
Also written Atacand.
A product of Candesartan; its studies count on that page too.
Keep track of what changes. Save the candesartan cilexetil studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
37 studies that test it; most in 2013 (5)
| Year | Studies |
|---|---|
| 1998 | 2 |
| 2001 | 2 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 4 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 5 |
| 2014 | 4 |
| 2015 | 2 |
| 2017 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 24 · Other 14
AstraZeneca (9) · HK inno.N Corporation (3) · GlaxoSmithKline (3) · Shin Poong Pharmaceutical Co. Ltd. (2) · Takeda (2) · Hospital Israelita Albert Einstein (1) · Uppsala University (1) · Pharmtechnology LLC (1)
Often tested with
Tested in the same studies.
Amlodipine (5) · Hydrochlorothiazide (3) · Lisinopril (2) · Ramipril (2) · Chlorthalidone (1) · Rosuvastatin (1) · Allopurinol (1) · Fimasartan (1)
Related medicines
As reviewed, each with the page that says it.
- A salt or form of Candesartan
- One of Angiotensin II Type 1 Receptor Blockers source
- One of Angiotensin Receptor Antagonists source
Studies
Open first, then newest update. How each study uses candesartan cilexetil is read from its arms, and is right about nine times in ten.
Testing it · 38
- Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)Enrolling by invitationPhase 4Baylor Research InstituteNCT07547878Written as Atacand
- Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain InjuryEnrolling by invitationPhase 2University of California, San FranciscoNCT05826912Written as Candesartan Cilexetil
- Candesartan Cilexetil + Chlorthalidone + Amlodipine Versus Exforge HCT®️ for Systemic Arterial HypertensionCompletedPhase 3Hospital Israelita Albert EinsteinNCT05920005Written as candesartan cilexetil + chlorthalidone + amlodipine
- Controlled Trial of Angiotensin Receptor Blocker (ARB) & Chemokine Receptor Type 2 (CCR2) Antagonist for the Treatment of COVID-19TerminatedPhase 2University of SydneyNCT05122182Written as Candesartan Cilexetil
- A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Candesartan Cilexetil MonotherapyCompletedPhase 3HK inno.N CorporationNCT02368652Written as Candesartan cilexetil 16mg
- The Precision Hypertension Care StudyCompletedPhase 4Uppsala UniversityNCT02774460Written as Atacand®
- The Bioequivalence Study of Two Different Formulations of Candesartan Cilexetil After a Single Oral Dose Administration Under Fasting ConditionsCompletedPhase 1Pharmtechnology LLCNCT04012307Written as Candesartan Cilexetil 32mg
- A Pilot Study of Candesartan as a Treatment for Cocaine DependenceTerminatedPhase 2Baylor College of MedicineNCT01938664Written as Candesartan with CBT
- Relative Bioavailability Study of Candesartan Cilexetil Under Fasting ConditionsCompletedPhase 1GlaxoSmithKlineNCT02254447Written as ATACAND
- Bioavailability Study of Candesartan Cilexetil 16mg Tablet Under Fasting ConditionsCompletedPhase 1GlaxoSmithKlineNCT02006602Written as Candesartan cilexetil (GW615775, Test formulation)
- Renal Response to Lower Body Negative Pressure in Pre-hypertensive StatesCompletedPhase 4PD Dr. Grégoire WuerznerNCT01734096Written as Candesartan cilexetil
- Bioavailability Study of Candesartan Cilexetil 8mg Tablet Under Fasting ConditionsCompletedPhase 1GlaxoSmithKlineNCT02006589Written as Candesartan cilexetil (GW615775, Test formulation)
- Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential HypertensionCompletedPhase 2BayerNCT01303783Written as Candesartan cilexetil (Atacand), 4 mg
- Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential HypertensionCompletedPhase 2Shin Poong Pharmaceutical Co. Ltd.NCT02944734Written as Candesartan Cilexetil 8mg
- Clinical Trial to Compare the Pharmacokinetics of DP-R208CompletedPhase 1Alvogen KoreaNCT02707224Written as Candesartan cilexetil
- Investigate a Interaction of Candesartan and Atorvastatin in Healthy Male SugjectsStatus unknownPhase 1Ahn-Gook Pharmaceuticals Co.,LtdNCT02609711Written as Candesartan cilexetil
- Diabetic Retinopathy Candesartan TrialsCompletedPhase 3AstraZenecaNCT00252733Written as candesartan cilexetil
- A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential HypertensionStatus unknownPhase 2HK inno.N CorporationNCT02059616Written as Candesartan Cilexetil 8mg
- Safety and Pharmacokinetics Study of Amlodipine 10mg and Candesartan 32mgCompletedPhase 1Shin Poong Pharmaceutical Co. Ltd.NCT01926652Written as candesartan cilexetil 32mg, amlodipine 10mg
- Pharmacokinetic Interactions of Candesartan Cilexetil and Amlodipine BesylateStatus unknownPhase 1HK inno.N CorporationNCT01845272Written as candesartan cilexetil 32mg, amlodipine 10mg
See all 38 studies that test candesartan cilexetil →
Given in every arm · 7 — candesartan cilexetil is usual care beside what is tested
- Safety and Tolerability of MK-5478 in Participants With Hypertension (5478-001)CompletedPhase 1Merck Sharp & Dohme LLCNCT01025843Written as Comparator: Candesartan cilexetil
- Efficacy and Safety of a Therapy Change From Candesartan 32 mg to Fixed Combination of Olmesartan 40 mg/Amlodipine 10 mgCompletedPhase 4Institut für Pharmakologie und Präventive MedizinNCT01611077Written as Candesartan cilexetil
- DP-R208 Pharmacokinetic StudyCompletedPhase 1Alvogen KoreaNCT02709187Written as Candesartan cilexetil
- Sevicontrol-1: Efficacy and Safety of a Fixed Combination of Olmesartan/ AmlodipineCompletedPhase 3Institut für Pharmakologie und Präventive MedizinNCT01613209Written as Candesartan cilexetil
- Bioequivalence Study of CJ-30059Status unknownPhase 1HK inno.N CorporationNCT02173912Written as Candesartan cilexetil 16 mg and Amlodipine besylate 10mg (Reference)
- Candesartan Effect in Second Stage Arterial HypertensionCompletedPhase 4AstraZenecaNCT00621153Written as Candesartan Cilexetil
- Antihypertensive Efficacy and Safety of Candesartan/HCT 32/12.5 and 32/25 mg in Comparison With Candesartan 32 mgCompletedPhase 3AstraZenecaNCT00383929Written as Candesartan cilexetil
As the comparator · 7 — what is tested is compared with candesartan cilexetil
- Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination TabletsCompletedPhase 4HK inno.N CorporationNCT03847506Written as Candesartan cilexetil/Amlodipine besylate
- A Phase 2 Dose-finding Study of TAK-272 in Participants With Type 2 Diabetes Mellitus and MicroalbuminuriaCompletedPhase 2TakedaNCT02332824Written as Candesartan cilexetil
- Monotherapy-Controlled Study of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Combination in Subjects With Essential Hypertension Inadequately Controlled on Candesartan CilexetilWithdrawnPhase 3BayerNCT02047019Written as Candesartan Cilexetil
- Single Dose Bioequivalence Study Comparing Nifedipine/Candesartan FDC (Fixed Dose Combination) With Loose Combination of Nifedipine GITS (Gastro-intestinal Therapeutic System) Plus Candesartan and Single Components Under Fasting ConditionsCompletedPhase 1BayerNCT01227603Written as Candesartan (Atacand)
- To Evaluate the Efficacy and Safety on Blood Pressure In Patients With Hypertension Diagnosed Congestive Heart FailureCompletedPhase 4Chong Kun Dang PharmaceuticalNCT01682564Written as Atacand tablet
- Effects of Telmisartan on Ischemic Cardiovascular Events in High-risk Hypertensive PatientsTerminatedNot applicableKyoto Prefectural University of MedicineNCT00863980Written as Blopress (Candesartan)
- Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential HypertensionCompletedPhase 2TakedaNCT01289132Written as Candesartan cilexetil
Codes
What other systems call candesartan cilexetil · ClinicalTrials.gg INT003675
- MeSH (NLM) C077793candesartan cilexetilConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) R85M2X0D68CANDESARTAN CILEXETILConfirmed FDA, NLM, Wikidata
- RxNorm 135481Confirmed FDA, Wikidata
- Wikidata Q27075664candesartan cilexetilConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C28903Candesartan CilexetilOne source FDA
- DrugBank DB00796One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C077793 | candesartan cilexetil | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | R85M2X0D68 | CANDESARTAN CILEXETIL | Confirmed FDA, NLM, Wikidata |
| RxNorm | 135481 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27075664 | candesartan cilexetil | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C28903 | Candesartan Cilexetil | One source FDA |
| DrugBank | DB00796 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.